Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

NCT04333407 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

320

Enrollment

OTHER

Sponsor class

Stopped Difficulty in recruiting eligible participants

Conditions

COVID-19

Interventions

DRUG: Aspirin 75mg
DRUG: Clopidogrel 75mg
DRUG: Rivaroxaban 2.5 MG
DRUG: Atorvastatin 40mg
DRUG: Omeprazole 20mg

Sponsor

Imperial College London